Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04664153 · ClinicalTrials.gov registry record · Phase 2

Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis

A Phase 2 study of Atopic Dermatitis and Plaque Psoriasis, sponsored by Pfizer.

Completed
Registry status
Phase 2
Development phase
104
Enrollment target
20
Study locations

NCT04664153 is a Phase 2 study of Atopic Dermatitis and Plaque Psoriasis that has completed, run by Pfizer. The registered enrollment target is 104 participants, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (83% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04664153, a Phase 2 study of Atopic Dermatitis and Plaque Psoriasis, has completed, sponsored by Pfizer.

COMPLETED
Registry status
Phase 2
Development phase
104 participants
Enrollment target
20
Study locations

Study Summary

This study is being conducted to provide data on efficacy, safety, tolerability and PK of PF-07038124 ointment versus vehicle control in the treatment of mild to moderate AD and mild to moderate plaque psoriasis.

Conditions Studied

Atopic Dermatitis Plaque Psoriasis

Interventions

  • DRUG PF-07038124 ointment
  • DRUG Vehicle ointment

Study Locations (20)

Florida

  • Renaissance Research and Medical Group - Cape Coral
  • Olympian Clinical Research - Clearwater
  • Moonshine Research Center, Inc. - Doral
  • Clinical Neuroscience Solutions - Orlando
  • Center for Clinical Studies - Tampa

Texas

  • studies in Dermatology, LLC - Cypress
  • Center for Clinical Studies - Houston
  • Center for Clinical Studies, LTD. LLP - Webster

Ontario

  • Dermatrials Research Inc. - Hamilton
  • Lynderm Research Inc. - Markham
  • DermEdge Research - Mississauga

Indiana

  • Dawes Fretzin Clinical Research Group, LLC - Indianapolis
  • The Indiana Clinical Trials Center, PC - Plainfield

California

  • First OC Dermatology - Fountain Valley

Michigan

  • Henry Ford Medical Center, New Center One - Detroit

North Carolina

  • M3 Wake Research, Inc. - Raleigh

Oregon

  • Oregon Dermatology and Research Center - Portland

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2020-12-21
Est. Completion 2021-08-18
Phase Phase 2

Sponsor

Pfizer

1,845 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04664153

The ClinicalTrials.gov registry entry for NCT04664153 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (83% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Atopic Dermatitis appearing as the primary indexed condition, and to 2 interventions - of which PF-07038124 ointment is the first listed.

NCT04664153 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Florida, Texas, Ontario.

Frequently Asked Questions

What is clinical trial NCT04664153 about?

NCT04664153 is a clinical study titled "Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis". This study is being conducted to provide data on efficacy, safety, tolerability and PK of PF-07038124 ointment versus vehicle control in the treatment of mild to moderate AD and mild to moderate plaque psoriasis.

What is the current status of trial NCT04664153?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 104 participants. The study started on 2020-12-21. Estimated completion is 2021-08-18.

What conditions does trial NCT04664153 study?

This clinical trial studies the following conditions: Atopic Dermatitis, Plaque Psoriasis.

What interventions are being tested in trial NCT04664153?

The interventions under investigation include: PF-07038124 ointment (DRUG), Vehicle ointment (DRUG).

Who is sponsoring clinical trial NCT04664153?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04664153 being conducted?

This trial has 20 study locations across California, Florida, Indiana, Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atopic Dermatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atopic Dermatitis

All registered trials for this condition

Plaque Psoriasis

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.